| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 130 | 0 | 0 | 10.676 | 11.361 | 16.103 | 30.131 | 25.778 | 28.567 |
| Total Income - EUR | - | 130 | 0 | 0 | 10.693 | 11.919 | 22.755 | 30.215 | 25.788 | 28.578 |
| Total Expenses - EUR | - | 2.571 | 37 | 31 | 1.452 | 7.914 | 12.371 | 9.312 | 15.538 | 14.451 |
| Gross Profit/Loss - EUR | - | -2.441 | -37 | -31 | 9.241 | 4.005 | 10.384 | 20.903 | 10.249 | 14.127 |
| Net Profit/Loss - EUR | - | -2.445 | -37 | -31 | 9.152 | 3.914 | 10.249 | 20.665 | 10.037 | 13.855 |
| Employees | - | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Tinosmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 71 | 33 | 1 | 0 | 0 | 5.944 | 4.336 | 2.702 | 1.075 |
| Current Assets | - | 573 | 563 | 553 | 7.459 | 11.209 | 14.412 | 21.272 | 15.542 | 15.652 |
| Inventories | - | 442 | 435 | 427 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 1.682 | 6.420 | 584 | 2.267 | 2.450 | 3.134 |
| Cash | - | 130 | 128 | 126 | 5.776 | 4.789 | 13.828 | 19.005 | 13.092 | 11.911 |
| Shareholders Funds | - | -2.400 | -2.396 | -2.383 | 6.857 | 10.641 | 15.227 | 20.762 | 14.970 | 13.952 |
| Social Capital | - | 45 | 44 | 43 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | - | 3.044 | 2.992 | 2.937 | 602 | 568 | 5.180 | 4.870 | 3.300 | 2.811 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8220 - 8220" | |||||||||
| CAEN Financial Year |
8220
|
|||||||||
Comments - Tinosmed S.r.l.